A new advanced diagnostic method for prostate cancer, now available in Romania

2026-09-14

Patients in Romania suffering from prostate cancer now have access to a state-of-the-art medical investigation method. It is the PSMA PET-CT, an advanced technology used for the precise evaluation of this oncological condition.

This medical procedure allows doctors to identify the spread of the disease in the body much more clearly. By using a specific tracer, the investigation can detect cancer cells even in early stages or in areas difficult to observe through traditional imaging methods, such as classic computed tomography or magnetic resonance imaging.

The introduction of this technology in medical centers across our country represents an important step for Romanian patients. They no longer have to travel abroad to benefit from an accurate diagnosis, which facilitates access to a personalized and much more efficient treatment plan.

Specialists emphasize that the precision offered by the PSMA PET-CT is essential for establishing the appropriate therapeutic approach. Depending on the results obtained, doctors can decide whether the patient needs surgery, radiotherapy, or other forms of systemic treatment.

The availability of this investigation in Romania marks an improvement in oncological care standards. Patients are advised to discuss with their attending physicians to find out if this procedure is indicated in their specific case and to receive guidance on accessing these medical services.